BEGIN:VCALENDAR
VERSION:2.0
PRODID:https://murmitoyen.com/events/vanille/udem/
X-WR-TIMEZONE:America/Montreal
BEGIN:VEVENT
UID:69ddb615757b8
DTSTAMP:20260413T233549
DTSTART:20151026T113000
SEQUENCE:0
TRANSP:OPAQUE
DTEND:20151026T123000
URL:https://murmitoyen.com/events/vanille/udem/detail/632987-low-dimensiona
 l-photophysics-for-biomedical-applications-n-d-heller-memorial-sloan-kette
 ring-cancer-center
LOCATION:Université de Montréal - Pavillon J.-Armand-Bombardier\, 5155\, 
 chemin de la rampe \, Montréal\, QC\, Canada\, H3T 2B2
SUMMARY:Low-Dimensional Photophysics for Biomedical Applications – D. Hel
 ler\, Memorial Sloan Kettering Cancer Center
DESCRIPTION:Dr. Daniel A. Heller\, Memorial Sloan Kettering Cancer Center\,
  1275 York Avenue\, New York\, NY 10065
\nOne of the most promising appl
 ications of nanotechnology is in the measurement of biological analytes. N
 ew methods are needed to image and quantify disease biomarkers and other b
 iological molecules. Nanomaterials could lead to better therapies\, earlie
 r cancer detection\, and better tools for biomedical research. The real-ti
 me and spatially-resolved detection and identification of bioanalytes in b
 iological media present important goals for next-generation nanoscale mate
 rials.
\n Towards this end\, certain low-dimensional nanomaterials offer 
 impressive photophysical properties\, such as high photostability\, near-i
 nfrared emission\, narrow spectral bandwidths\, and unique environmental s
 ensitivity. To build biomedical technologies using these materials\, a bet
 ter understanding of their properties\, as well as new methods to measure 
 them\, are needed.
\nMy laboratory is exploring the intrinsic near-infrare
 d fluorescence of single-walled carbon nanotubes. To build optical probes 
 using these materials\, we developed new imaging techniques to detect nano
 tube emission in biological environments and new materials to control thei
 r optical properties. Our goal is to develop new tools to allow biologists
  to ask previously unanswerable questions and to give clinicians better in
 formation about their patients.
\n 
\nBio: 
\nDr. Daniel Heller is an Ass
 istant Member at Memorial Sloan-Kettering and Assistant Professor at Weill
  Cornell Medical College. His work focuses on nanoscale technologies\, inc
 luding optical biosensors for cancer research and diagnosis\, and targeted
  nanoparticles to treat metastatic cancer. Dr. Heller obtained a BA in his
 tory from Rice University in 2000 and a PhD in chemistry from the Universi
 ty of Illinois in 2010. He completed a Damon Runyon Postdoctoral Fellowshi
 p in the laboratory of Robert Langer at the David H. Koch Institute for In
 tegrative Cancer Research at MIT and is a 2012 recipient of the National I
 nstitutes of Health Director’s New Innovator Award and a 2015 Kavli Fell
 ow
\n 
\nSite web du groupe du Dr Heller
\nCette conférence est présen
 tée par le RQMP Versant Nord du Département de physique de l'Univers
 ité de Montréal et le Département de génie physique de Polytechnique
  Montréal.
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Montreal
X-LIC-LOCATION:America/Montreal
END:VTIMEZONE
END:VCALENDAR